Article Data

  • Views 503
  • Dowloads 158

Original Research

Open Access

Dexmedetomidine improves myocardial ischemia-reperfusion injury by increasing autophagy via PINK1/PRKN pathway

  • Lu Liu1
  • Xiaojun Ji2
  • Xumei Huang2,*,

1Department of Anesthesiology, Wuhan Children’s Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430014 Wuhan, Hubei, China

2Department of Cardiology, Wenzhou Central Hospital, 325000 Wenzhou, Zhejiang, China

DOI: 10.22514/sv.2022.061 Vol.18,Issue 5,September 2022 pp.125-132

Submitted: 25 May 2022 Accepted: 14 July 2022

Published: 08 September 2022

*Corresponding Author(s): Xumei Huang E-mail: xm_h73@163.com

Abstract

Ischemic heart disease poses a great threat to human life with its high morbidity and mortality. Timely reperfusion is considered as the most effective intervention for clinical treatment of myocardial ischemia. Reperfusion can commonly lead to cell death and myocardial injury. There has already been evidence that dexmedetomidine (DEX) can protect the injury of myocardial ischemia reperfusion (MI/R). The aims of this research are to explain DEX’s functions in protecting MI/R injury as well as probing into its inner mechanisms. H9c2 cells was adopted to generate the injury of MI/R cell as a result of hypoxia/reoxygenation (H/R). MTT test was used to examine cell activity and flow cytometry was utilized to check cell apoptosis rate. Western blot test was adopted to appraise the protein expressions of Parkin RBR E3 ubiquitin protein ligase (PRKN or Parkin), PTEN-induced kinase-1 (PINK1) and markers associate with autophagy (Light Chain 3-II/I (LC3-II/I)). Immunofluorescence was applied to estimate the LC3 level. Next, the function of DEX in protecting the injury of H/R induced cell by PINK1/PRKN pathway was confirmed. DEX treatment significantly promoted viability, improved apoptotic rate and increased autophagy in H9c2 cells processed by H/R. Moreover, the protein expressions of PINK1 and PRKN were boosted by DEX, suggesting that DEX induced autophagy through the activation of PINK1/PRKN signaling pathway. In later tests, PINK1 teardown weakened DEX’s effect the injury of myocardial cell induced by H/R. DEX improves MI/R injury by inducing autophagy through activating PINK1/PRKN pathway.


Keywords

Myocardial ischemia-reperfusion; Dexmedetomidine; Autophagy; Apoptosis; PINK1


Cite and Share

Lu Liu,Xiaojun Ji,Xumei Huang. Dexmedetomidine improves myocardial ischemia-reperfusion injury by increasing autophagy via PINK1/PRKN pathway. Signa Vitae. 2022. 18(5);125-132.

References

[1] Gewirtz H, Dilsizian V. Myocardial viability: survival mechanisms and molecular imaging targets in acute and chronic ischemia. Circulation Research. 2017; 120: 1197–1212.

[2] Heusch G. Myocardial ischaemia–reperfusion injury and cardioprotection in perspective. Nature Reviews Cardiology. 2020; 17: 773–789.

[3] Gazmuri RJ, Ayoub IM, Radhakrishnan J. Myocardial effects of cardiac arrest and resuscitation with especial reference to mitochondrial injury. Signa Vitae. 2008; 3: 7–12.

[4] Powers SK, Smuder AJ, Kavazis AN, Quindry JC. Mechanisms of exercise-induced cardioprotection. Physiology. 2014; 29: 27–38.

[5] Du J, Li YL, Zhao W. Autophagy and myocardial ischemia. Advances in Experimental Medicine and Biology. 2020; 32: 217–222.

[6] Doherty J, Baehrecke EH. Life, death and autophagy. Nature Cell Biology. 2018; 20: 1110–1117.

[7] Wu SY, Chang GL, Gao L, Jiang D, Wang LY, Li GX, et al. Trimetazidine protects against myocardial ischemia/reperfusion injury by inhibiting excessive autophagy. Journal of Molecular Medicine. 2018; 96: 791–806.

[8] Mo YL, Tang L, Ma Y, Wu SZ. Pramipexole pretreatment attenuates myocardial ischemia/reperfusion injury through upregulation of autophagy. Biochemical and Biophysical Research Communications. 2016; 473: 1119–1124.

[9] Kawazoe Y, Miyamoto K, Morimoto T, Yamamoto T, Fuke A, Hashimoto A, et al. Effect of dexmedetomidine on mortality and ventilator-free days in patients requiring mechanical ventilation with sepsis: a randomized clinical trial. Journal of the American Medical Association. 2017; 317: 1321–1328.

[10] Sun ZX, Zhao TY, Lv SJ, Gao Y, Masters J, Weng H. Dexmedetomidine attenuates spinal cord ischemia–reperfusion injury through both anti-inflammation and anti-apoptosis mechanisms in rabbits. Journal of Translational Medicine. 2018; 16: 209.

[11] Zhang X, Li YX, Wang Y, Zhuang YR, Ren XJ, Yang K, et al. Dexmedetomidine postconditioning suppresses myocardial ischemia/reperfusion injury by activating the SIRT1/mTOR axis. Bioscience Reports. 2020; 40: BSR20194030.

[12] Yu TY, Liu D, Gao M, Yang PL, Zhang M, Song F, et al. Dexmedetomidine prevents septic myocardial dysfunction in rats via activation of α7nAChR and PI3K/Akt- mediated autophagy. Biomedicine & Pharmacotherapy. 2019; 120: 109231.

[13] Pickrell AM, Youle RJ. The roles of PINK1, parkin, and mitochondrial fidelity in parkinson’s disease. Neuron. 2015; 85: 257–273.

[14] Lazarou M, Jin SM, Kane LA, Youle RJ. Role of PINK1 Binding to the TOM complex and alternate intracellular membranes in recruitment and activation of the E3 ligase parkin. Developmental Cell. 2012; 22: 320–333.

[15] Eiyama A, Okamoto K. PINK1/Parkin-mediated mitophagy in mammalian cell. Current Opinion in Cell Biology. 2015; 33: 95–101.

[16] Wang YY, Mao X, Chen HG, Feng JC, Yan MY, Wang YQ, et al. Dexmedetomidine alleviates LPS-induced apoptosis and inflammation in macrophages by eliminating damaged mitochondria via PINK1 mediated mitophagy. International Immunopharmacology. 2019; 73: 471–481.

[17] Liu WH, Chen CG, Gu XJ, Zhang L, Mao X, Chen ZL, et al. AM1241 alleviates myocardial ischemia-reperfusion injury in rats by enhancing Pink1/Parkin-mediated autophagy. Life Sciences. 2021; 272: 119228.

[18] Qiu Z, He YH, Ming H, Lei SQ, Leng Y, Xia ZY. Lipopolysaccharide (LPS) aggravates high glucose- and hypoxia/reoxygenation-induced injury through activating ROS-Dependent NLRP3 inflammasome-mediated pyroptosis in H9C2 cardiomyocytes. Journal of Diabetes Research. 2019; 2019: 8151836.

[19] Tang L, Mo YL, Li YP, Zhong YK, He SF, Zhang Y, et al. Urolithin a alleviates myocardial ischemia/reperfusion injury via PI3K/Akt pathway. Biochemical and Biophysical Research Communications. 2017; 486: 774–780.

[20] Shang ZF, Wei Q, Yu L, Huang F, Xiao BB, Wang H, et al. Suppression of PC-1/PrLZ sensitizes prostate cancer cells to ionizing radiation by attenuating DNA damage repair and inducing autophagic cell death. Oncotarget. 2016; 7: 62340-62351.

[21] Zheng X, Zhang J, Li S, Gao X, Zhang Y, Wang M, et al. Low doses of niclosamide and quinacrine combination yields synergistic effect in melanoma via activating autophagy-mediated p53-dependent apoptosis. Translational Oncology. 2022; 21:101425.

[22] Korshunova AY, Blagonravov ML, Neborak EV, Syatkin SP, Sklifasovskaya AP, Semyatov SM, et al. BCL2-regulated apoptotic process in myocardial ischemia-reperfusion injury. International Journal of Molecular Medicine. 2021; 47: 23–26.

[23] Frank A, Bonney M, Bonney S, Weitzel L, Koeppen M, Eckle T. Myocardial ischemia reperfusion injury: from basic science to clinical bedside. Seminars in Cardiothoracic and Vascular Anesthesia. 2012; 16: 123–132.

[24] Afonso J, Reis F. Dexmedetomidine: current role in anesthesia and intensive care. Brazilian Journal of Anesthesiology. 2012; 62: 118–133.

[25] Wang HK, Xia Y, Sun ZQ. Dexmedetomidine: a potential therapy for myocardial ischemia/reperfusion injury. International Journal of Cardiology. 2021; 335: 104.

[26] Huang Y, Sun XT, Juan ZD, Zhang R, Wang RG, Meng SQ, et al. Dexmedetomidine attenuates myocardial ischemia-reperfusion injury in vitro by inhibiting NLRP3 Inflammasome activation. BioMed Central Anesthesiology. 2021; 21: 104.

[27] Yang YF WH, Song N, Jiang YH, Zhang J, Meng XW, et al. Dexmedetomidine attenuates ischemia/reperfusion-induced myocardial inflammation and apoptosis through inhibiting endoplasmic reticulum stress signaling. Journal of Inflammation Research. 2021; 14: 1217–1233.

[28] Meyer G, Czompa A, Reboul C, Csepanyi E, Czegledi A, Bak I, et al. The cellular autophagy markers Beclin-1 and LC3B-II are increased during reperfusion in fibrillated mouse hearts. Current Pharmaceutical Design. 2013; 19: 6912–6918.

[29] Gustafsson AB, Gottlieb RA. Autophagy in ischemic heart disease. Circulation Research. 2009; 104: 150–158.

[30] Matsui Y, Takagi H, Qu X, Abdellatif M, Sakoda H, Asano T, et al. Distinct roles of autophagy in the heart during ischemia and reperfusion : roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circulation Research. 2007; 100: 914–922.

[31] Zhao R, Xie E, Yang XB, Gong B. Alliin alleviates myocardial ischemia-reperfusion injury by promoting autophagy. Biochemical and Biophysical Research Communications. 2019; 512: 236–243.


Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.

IndexCopernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.

Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.

Scopus: CiteScore 0.5(2021) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.

Submission Turnaround Time

Conferences

Top